Key result
Early-onset severe preeclampsia is linked to ~2.2-fold higher maternal serum MMP-3 levels.
Why the study?
Do maternal serum levels of MMP-2, MMP-3, MMP-9, and MMP-13 differ between women with severe early-onset preeclampsia, severe late-onset preeclampsia, and healthy uncomplicated pregnancies?
Case-Control (n=125)
No
Do maternal serum levels of MMP-2, MMP-3, MMP-9, and MMP-13 differ between women with severe early-onset preeclampsia, severe late-onset preeclampsia, and healthy uncomplicated pregnancies?
Elevated maternal serum MMP-3 is uniquely associated with severe early-onset preeclampsia (and not late-onset disease), whereas elevated MMP-2 is present in both subtypes, highlighting distinct pathophysiological mechanisms of trophoblast invasion vs. maternal vascular dysfunction.
Answers are grounded in this paper and cite their sources.
May aid early-onset preeclampsia identification; leaves open subtype-specific mechanisms for prospective validation.
OBJECTIVE: The aim of this study was to determine whether maternal serum matrix metalloproteinases 2, 3, 9, and 13 levels differ in early- and late-onset preeclampsia and uncomplicated pregnancies. PATIENTS AND METHODS: The study was carried out in 125 pregnant women (29 with early-onset preeclampsia; 31 preeclamptic patients with late-onset preeclampsia; and 65 healthy pregnant controls). Levels of MMP-2, MMP-3, MMP-9, and MMP-13 were measured in the maternal serum using an enzyme-linked immunosorbent assay. RESULTS: Maternal serum MMP-2 levels in both the groups of preeclamptic women were significantly higher than those in the controls. Levels of MMP-3 were significantly higher in preeclamptic patients with early-onset disease; however, the MMP-3 levels in patients with late-onset preeclampsia were similar to those observed in the control subjects. MMP-9 levels were lower whereas the levels of MMP-13 were higher in both preeclamptic groups of pregnant women than in the healthy controls, but these differences were statistically insignificant. CONCLUSIONS: One important finding of the present study was that MMP-3 appears to be involved solely in early-onset preeclampsia, but not in late-onset preeclampsia. Higher levels of MMP-2 and MMP-13 and lower levels of MMP-9 seem to be related to both early- and late-onset severe preeclampsia.
No takes yet. Share an insight, caveat, or question.
Marzena Laskowska (2017) conducted a case-control in Severe early- and late-onset preeclampsia (n=125). Severe early-onset (<34 weeks) and late-onset (≥34 weeks) preeclampsia vs. Healthy normotensive third-trimester pregnant controls was evaluated on Maternal serum matrix metalloproteinase-3 (MMP-3) concentration (ng/mL) in early-onset preeclampsia vs. controls (p=<0.05). Early-onset severe preeclampsia was associated with higher maternal serum MMP-3 levels and elevated MMP-2 levels.
Synapse has enriched 10 related papers. Consider them for comparative context: